Booth: 305, 210

AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.



Booth: 117

AcariaHealth is a national comprehensive specialty pharmacy focused on improving care and outcomes for patients living with complex and chronic health conditions, including Hepatitis C and other liver diseases. Our specialized care management services put patients first, bringing a personal touch to specialty drug management.



Booth: 111

Accredo is a full-service specialty pharmacy dedicated to the treatment of rare and complex conditions. Our comprehensive therapy management programs engage trained pharmacists, nurses, reimbursement specialists, and patient care representatives who provide enhanced support services to patients, their families and healthcare professionals.

Allergan USA, Inc.


Booth: 712

Allergan plc (NYSE: AGN), is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. For more information, visit Allergan’s website at

American Porphyria Foundation


Booth: 1112

The mission of the American Porphyria Foundation is to enhance awareness and education about the Porphyrias and to aid in advancing treatment of this group of disorders.

Amsety LLC


Booth: 331

Amsety has developed the first nutrition bar to support liver health. Designed by a team of liver health specialists, scientists and food engineers, Amsety Bars meet the dietary requirements for liver diet. Amsety possesses a marketing database of around 300,000 qualified addresses of liver patients.

Asociacion Latinoamericana para el Estudio del Hígado ALEH


Booth: 1118

ALEH is a Non-profit scientific association, whose main objective is to promote and disseminate the study of Hepatology in Latin America. ALEH seeks to establish solid leadership within the field at a global level via diverse activities: Training and the exchange of scientific knowledge to reduce gaps in the region.

Autoimmune Hepatitis Association, Inc.


Booth: 1104

The Autoimmune Hepatitis Association (AIHA) is a nonprofit that offers education and support for patients and families affected by autoimmune hepatitis. The AIHA hosts a biennial patient conference (next one is July 2019 in Indianapolis) and a social media community that connects patients with one another and with research opportunities.

Baxter Healthcare Corporation


Booth: 1232

Baxter products help make care options more accessible for critically-ill patients. We're advancing care for patients with drug overdose and poisoning, which can result in liver cell injury or death, and acute kidney injury worldwide. We provide a full range of dialysis, and drug overdose and poisoning therapy options, including MARS therapy and CRRT.

Bayer Healthcare


Booth: 821

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.



Booth: 1022

AcariaHealth is a national comprehensive specialty pharmacy focused on improving care and outcomes for patients living with complex and chronic health conditions, including Hepatitis C and other liver diseases. Our specialized care management services put patients first, bringing a personal touch to specialty drug management.



Booth: 222

BioPredictive is benchmark in blood tests for liver diseases. BioPredictive is dedicated to improve the management of liver diseases. Over 2.5 million tests performed worldwide. BioPredictive’s diagnosis and prognosis patented tests (FiboTest-ActiTest, SteatoTest, and just released in 2019 the NASH-Fibro Test) are available at

Blue Faery: The Adrienne Wilson Liver Cancer Association


Booth: 114

Blue Faery's mission is to prevent, treat and cure primary liver cancer, specifically Hepatocellular Carcinoma, through research, education and advocacy.



Booth: 1204

Optum Specialty is a leading specialty pharmacy services company dedicated to helping administer and deliver high-quality, cost-effective specialty pharmacy care. Optum Specialty Pharmacy combines technology, data and expertise to provide educational resources, 24/7 pharmacy support and trusted advice to the individuals, caregivers and care teams we serve.

Bristol-Myers Squibb


Booth: 606

Bristol-Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular and neuroscience. Our employees work every day to transform patients’ lives through science.

Canadian Association for the Study of the Liver


Booth: 116

The Canadian Association for the Study of the Liver (CASL) is a multidisciplinary group of scientists and healthcare providers whose expertise focuses on the liver. We provide national leadership in all aspects of hepatology research, education and patient care, and publish the Canadian Liver Journal.

Charles River


Booth: 1020

Discovery from Charles River is the CRO of choice with a proven track record of successful drug development. Offering scientific excellence and integrated services that take clients from hit ID to IND, our client-focused collaborative team works with clients to find and follow the optimum path to market.

Cholangiocarcinoma Foundation, The


Booth: 102

Founded in 2006, the Cholangiocarcinoma Foundation is a global 501(c) (3) non-profit organization whose mission is to find a cure and improve the quality of life for those affected by bile duct cancer.  

Chronic Liver Disease Foundation


Booth: 1113

The Chronic Liver Disease Foundation (CLDF) is an educational organization dedicated to increasing the awareness of the effects of chronic liver disease in the United States. The CLDF's goal is to provide healthcare professionals with the most current education and information on chronic liver disease.  

Cochrane Hepato-Biliary Group, The


Booth: 104

The Cochrane Hepato-Biliary Group (CHBG), part of Cochrane, is a non-profit, non-industry funded international clinical research group with 2300 members. In issue 6, 2019 of The Cochrane Library, we published 371 peer-reviewed protocols and 223 systematic reviews. A CHBG Register with RCTs and CCTs is maintained in The Cochrane Library.

Community Liver Alliance


Booth: 1105

The Community Liver Alliance (CLA), headquartered in Pittsburgh, PA., is a 501(c)(3) non-profit, community-based organization dedicated to promoting liver health and liver disease awareness, prevention, education, advocacy and research.

CTI Clinical Trial and Consulting


Booth: 211

CTI Clinical Trial and Consulting, is a global, therapeutically focused, full-service contract research organization entering into its third decade in business. CTI specializes in complex programs in critically-ill patients, providing its partners with clinical and disease area expertise in hepatology, transplantation, immunology, rare diseases, regenerative medicine/gene therapy, nephrology, hematology/oncology, neurology, infectious diseases, and pediatric populations.

CVS Specialty


Booth: 825

Our commitment to helping patients and their physicians manage complex drug therapies by delivering expert individualized care and unmatched, multi-channel access has made us one of the leading specialty pharmacies in the country. We provide a full-range of pharmaceutical care, dispensing the latest FDA-approved medications.

CymaBay Therapeutics


Booth: 1003

CymaBay Therapeutics is a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need.

Cytotheryx Inc.


Booth: 430

Cytotheryx is a biomedical research company developing a consistent, high-quality source of human hepatocytes (HHCs) for research and clinical applications. HHCs are used in toxicology studies, hepatitis research and transplants. Our foundational science will increase supply, enabling applications in liver assist devices, cell and gene therapy, drug delivery and allotransplantation.

DiaPharma Group, Inc


Booth: 1224

Diapharma offers non-invasive biomarker assays for research of liver injury, metabolic syndrome, and associated pathologies. Explore M30® and M65® Cytokeratin/Keratin 18 ELISAs for studying hepatocyte apoptosis/necrosis, and see what’s new in biomarkers for NASH, AH, and DILI research at booth 1224. Research use only in U.S. and Canada.

DILIsym Services


Booth: 1238

DILIsym Services, Inc. is committed to providing the pharmaceutical industry with the tools, resources and information to more efficiently develop safe and effective therapies for patients who need them. DILIsym Services, Inc. has developed and applies the NAFLDsym®, DILIsym®, RENAsym™, IPFsym™ and RADAsym® modeling software to support these objectives.

Dova Pharmaceuticals


Booth: 429

Dova is a clinical-stage pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is a high unmet medical need. With a nimble approach and a team of bright minds aglow with passion, we’re dedicated to bringing brilliant medicine to market.

Dynavax Technologies


Booth: 1212

Dynavax is a commercial-stage biopharmaceutical company. Our FDA-approved hepatitis B vaccine is the only two-dose hepatitis vaccine for adults that completes the series in 1 month. It is the first approved hepatitis B vaccine in over 25 years and received a unanimous recommendation from the Advisory Committee on Immunization Practice.

Echosens North America, Inc.


Booth: 405

Echosens™ is the world's leading provider of non-invasive, point of care medical devices for the liver. FibroScan ® is FDA cleared as an aid for the non-invasive diagnosis and monitoring of liver disease. Supported by over 2,000 peer reviewed publications Fibroscan is the reference for major treatment guidelines in liver disease.

Eiger BioPharmaceuticals, Inc.


Booth: 1248

Eiger is a late stage biopharmaceutical company focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases. The company’s lead program is in Phase 3, developing lonafarnib, a first-in-class prenylation inhibitor for the treatment of Hepatitis Delta Virus (HDV) infection.

Eisai Inc.


Booth: 718

As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we are a fully integrated pharmaceutical business with discovery, clinical, and marketing capabilities. Our key areas of focus include oncology and neurology (dementia-related diseases and neurodegenerative diseases). To learn more about Eisai Inc., please visit us at

Enanta Pharmaceuticals


Booth: 1210

Enanta Pharmaceuticals is developing small molecule drugs for respiratory syncytial virus (RSV), non-alcoholic steatohepatitis (NASH)/primary biliary cholangitis (PBC), and hepatitis B virus (HBV). Enanta’s R&D activities are funded by royalties from hepatitis C products developed under its collaboration with AbbVie including glecaprevir which is sold under tradenames MAVYRET® and MAVIRET™.

ENDRA Life Sciences


Booth: 1200

ENDRA Life Sciences (NASDAQ: NDRA) is a development stage company with a breakthrough Thermo-Acoustic Enhanced UltraSound (TAEUS) device that will enable clinicians to visualize human tissue composition, function and temperature. Initial application is quantification of fat in the liver, for early detection and monitoring of NAFLD, which affects over 1 billion people globally.

European Association for the Study of the Liver (EASL)


Booth: 1115

Since 1966, EASL has continued to grow into a major European Association with international influence dedicated to liver research. It has over 4,500 members and its International Liver Congress™ unites over 9,000 liver experts. EASL supports clinical trials and research to the benefit of patients world-wide.

Exact Sciences Corporation

Booth: 829

Visikol is a CRO focused on advanced drug discovery that is leading the fields of bio-imaging, bioinformatics and image analysis. We conduct end-to-end drug discovery services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, digital pathology and custom drug discovery projects.

ExeGi Pharma


Booth: 1228

ExeGi Pharma distributes Visbiome, a high potency probiotic medical food intended for the dietary management of dysbiosis associated with irritable bowel syndrome, ulcerative colitis, pouchitis and hepatic encephalopathy. Visbiome offers a very high potency of bacteria ranging from 112.5 billion bacteria per CFU-900 billion bacteria per CFU, depending on the product. Visbiome is available in capsules, packets, and prescription-strength packets.

Exelixis, Inc.


Booth: 610, 726

Founded in 1994, Exelixis, Inc. is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Exelixis is on a mission to help patients recover stronger and live longer.

FUJIFILM Wako Diagnostics U.S.A. Corporation


Booth: 622

FUJIFILM Wako Diagnostics offers biomarkers AFP-L3 (lectin-reactive alpha-fetoprotein) and DCP (des-gamma-carboxy prothrombin, also-known-as PIVKA-II), intended to aid in risk assessment of chronic liver disease patients for development of HCC in conjunction with other laboratory findings, imaging studies and clinical assessment. They are CMS reimbursed and available at major reference laboratories.

Galmed Pharmaceuticals, Ltd.


Booth: 602

Galmed Pharmaceuticals (Nasdaq: GLMD) is a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis, is currently in a Phase 3/4 registrational study (the ARMOR study), conducted in 15 countries including the U.S., Europe, Latin America and Asia.

Gastroenterology and Endoscopy News


Booth: 1226

Gastroenterology & Endoscopy News, a monthly newspaper, provides smart, objective and comprehensive clinical news reporting from international, national and regional gastroenterology meetings. It also features in-depth original articles, educational reviews, CME monographs and monthly commentary from celebrated gastroenterologists.

Gastroenterology and Hepatology


Booth: 1244

Gastroenterology & Hepatology is a monthly, independent peer-reviewed journal that is mailed to all US gastroenterologists and hepatologists (16,700+). Content is directed by strong input of experts in the field. G&H contains thoughtful leader-driven review articles, clinical case studies with expert commentary, and advances columns featuring engaging interviews with experts on current issues in IBD, IBS, GERD, Hepatitis and Endoscopy.



Booth: 416, 312

GENFIT, a biopharmaceutical company focused on discovering and developing therapeutic and diagnostic solutions in metabolic/liver diseases, is evaluating elafibranor in a P3 trial in NASH as well as in PBC. GENFIT is also developing NIS4™, a novel blood-based in vitro diagnostic test to easily identify NASH patients.

Gilead Sciences, Inc.


Booth: 1258, 701, 801, 912

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.



Booth: 423

GSK is a science-led global healthcare company with a mission to help people do more, feel better, live longer. We research, manufacture and make available a broad range of medicines, vaccines and consumer healthcare products. Visit our exhibit for information about our products and resources.

Gore & Associates


Booth: 216

Gore Medical Products Division engineers devices that treat a range of cardiovascular, bariatric, hernia and other health conditions. Gore builds on its legacy of improving patient outcomes through research, education, and quality initiatives. Product performance, ease of use, and quality of service provide sustainable clinical and economic value for physicians, hospitals, and insurers.

HealthWell Foundation


Booth: 1103

The HealthWell Foundation is an independent non-profit dedicated to reducing financial barriers to care for underinsured Americans with chronic and life-altering medical conditions. HealthWell offers a financial lifeline to adults and children who desperately need critical medical treatments but can't afford them by assisting with their cost-sharing obligations. Learn more:

Hepatiq, Inc.


Booth: 1007

HEPATIQ is the first automated software to precisely quantitate liver function using nuclear medicine images. Liver function can be reduced by infections, alcohol and fat buildup. The liver can generate new functioning nodules, and blood flow to the liver may also increase, hence mitigating some of the damage. Thus, measuring liver function is very important.



Booth: 1240

IIAM is a world-leading provider of non-transplantable, human organs and tissues for medical research, therapeutic applications and pre-clinical investigations. As a non-profit with more than 30 years of experience in the field, IIAM is a known and trusted partner to both organ procurement organizations and research institutions worldwide.

INDIGO Biosciences, Inc.


Booth: 924

INDIGO Biosciences is a leading provider of nuclear receptor and in vitro toxicology solutions that accelerate scientific decision-making, supplementing the world’s largest portfolio with greater results readability, reproducibility, and faster turnaround times. Our solutions aim to reduce the time, cost, and risk associated with the discovery process.

Insphero Inc.


Booth: 926

InSphero is the pioneer of scalable, 3D-cell-based assay solutions and organ-on-a-chip technology for drug discovery and safety testing. Through partnerships, InSphero supports pharma and biotech researchers in successful decision-making with innovative 3D in vitro platforms and models that accurately recapitulate healthy and diseased human physiology.

Intercept Pharmaceuticals


Booth: 105

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. Founded in 2002 in New York, Intercept now has operations in the United States, Europe and Canada.



Booth: 428

Covance is the world's most comprehensive drug development company. LabCorp, our parent company, is a market leader in diagnostics with strength in the management of infectious diseases. Together, we offer a single-source solution for drug development and treatment of acute and chronic infections. Together, we improve health and improve lives.

Madrigal Pharmaceuticals


Booth: 417

Madrigal Pharmaceuticals is a biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone pathway in the liver to address a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need. Resmetirom, the lead compound, is currently being evaluated in the global Phase 3 study MAESTRO-NASH.

Mallinckrodt Pharmaceuticals


Booth: 925

Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. To learn more visit

Novartis Pharma AG


Booth: 408

Novartis, a leading global medicines company, is reimagining medicine to improve and extend people’s lives through innovation and digital technologies to create transformative treatments in areas of great medical need. Novartis reaches more than 750 million people and we are finding innovative ways to expand access to our latest treatments.

Novo Nordisk A/S


Booth: 921

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders, obesity, chronic kidney disease, cardiovascular disease and NASH.

Owlstone Medical


Booth: 828

Founded in 1994, Exelixis, Inc. is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Exelixis is on a mission to help patients recover stronger and live longer.

PBCers Organization


Booth: 1102

PBCers Organization is a nonprofit offering support and education to patients with Primary Biliary Cholangitis with our online resources and hosting a biennial patient conference. We raise funds for research, connect patients with research opportunities and our patient registry assists future research.

Perspectum Diagnostics LTD


Booth: 409

Perspectum Diagnostics provides digital health solutions for metabolic disease. LiverMultiScan, uses multiparametric MRI to provide quantitative analysis of liver tissue, measuring fat, correlates of iron and fibroinflammatory disease. MRCP+, allows 3D visualisation and quantitative mapping of the pancreatobiliary system by enhancing conventional MRCP images

Pfizer Inc.


Booth: 909

Founded in 1849, Pfizer is the world’s largest research-based pharmaceutical company taking new approaches to better health.  We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals.  

PhoenixBio USA Corporation


Booth: 729

PhoenixBio provides access to the PXB-Mouse® (chimeric mouse model featuring a humanized liver, up to 98% human hepatocyte engraftment) and PXB-cells® (human hepatocytes freshly isolated from PXB-mice) for in vivo and in vitro liver related research areas. PhoenixBio models accelerate pharmaceutical and chemical compound development by better predicting human outcomes.

Precision MedCare


Booth: 515

Precision MedCare is a Medical AI startup founded in Atlanta. Based on its proprietary technology that utilizes ultrasound Doppler device to measure, Precision MedCare offers hospitals and clinics new and accurate solutions for liver fibrosis detection.

ProSciento, Inc.


Booth: 1234

ProSciento is a global CRO exclusively focused on NASH, diabetes and obesity. ProSciento provides comprehensive and customized services for multinational, early development clinical trial programs for biopharma companies worldwide. Founded in 2003, ProSciento has completed over 300 clinical projects and contributed to more than 16 approved metabolic drugs and devices.

PSC Partners Seeking a Cure


Booth: 110

PSC Partners Seeking a Cure provides education and support to PSC patients, families and caregivers, and raises funds to research causes, treatments and cures for Primary Sclerosing Cholangitis. PSC Partners has awarded $3 million in research grants, has a growing patient registry, and holds annual conferences for patients and caregivers.

Research Diets, Inc.


Booth: 1230

Research Diets, Inc. formulates and produces purified OpenSource Diets® for laboratory animals. Custom diets shipped in 5-7 days. BioDAQ® Food and Liquid Intake Monitor for mice and rats mounts to home cage and records the time, duration, amount of each meal automatically. BioDAQ NHP monitors food intake of socially housed NHPs.

Resoundant Inc.


Booth: 824

Resoundant Inc. is the developer of Magnetic Resonance Elastography (MRE), an advanced imaging technology for measuring tissue stiffness and aiding the diagnosis and staging of liver fibrosis. MRE is available at over 1300 leading imaging centers and hospitals throughout the world. Follow us @Resoundant or visit us at Booth # 627.

Salix Pharmaceuticals, Inc. Valeant


Booth: 812

For 30 years, Salix Pharmaceuticals has been committed to the prevention and treatment of gastrointestinal diseases. Salix licenses, develops and markets innovative products to improve patients’ lives and arm healthcare providers with life-changing solutions. Salix is headquartered in Bridgewater, New Jersey.

Siemens Healthineers


Booth: 1260

Siemens Healthcare help you address challenging clinical needs in the management of patients with chronic liver disease and the assessment of liver fibrosis, including Virtual Touch™ software applications* on the ACUSON S2000 ultrasound system, (an implementation of acoustic radiation force impulse (ARFI) imaging).  

University of Pittsburgh Medical Center


Booth: 1214

Since the program's inception in 1981, UPMC Transplant Services has been a pioneer in the development and refinement of new transplant procedures. UPMC is committed to reducing waiting list deaths through robust living-donor kidney and living-donor liver transplant programs, as well as other innovative methods to expand the donor pool.

Virology Education


Booth: 212

Virology Education is a leading provider of innovative scientific and educational programs worldwide, with over 20 years of experience and a wide network of experts. Our programs provide platforms for scientific exchange, education and knowledge-sharing tailored to the needs of healthcare professionals in the fields of virology and liver disease.

Visikol, Inc.


Booth: 1024

Visikol is a CRO focused on advanced drug discovery that is leading the fields of bio-imaging, bioinformatics and image analysis. We conduct end-to-end drug discovery services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, digital pathology and custom drug discovery projects.



Booth: 220

Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments, and individuals increase the academic and professional impact of their work.

World Gastroenterology Organisation


Booth: 1116

The World Gastroenterology Organisation (WGO) is a federation comprised of over 110 gastroenterology, hepatology, endoscopy, and other related-discipline societies representing more than 50,000 individuals worldwide. WGO focuses on the improvement of standards in gastroenterology training and education globally. The WGO Foundation is the philanthropic resource for the WGO mission.

WuXi AppTec


Booth: 1242

WuXi AppTec is a full-service provider of open-access capabilities and technology that enable customers worldwide to advance discoveries in the health sciences and deliver treatment to those in need.